Why Choose LDN Over GLP-1 Injectables
Cirilo, M., Coccia, M.E., Attanasio, M and Fatini, C
The clinician designed a comprehensive repair plan: Anti-inflammatory Mediterranean-style , rich in Metabolic Typing targeted diet prebiotic fiber Resistance training three times per week Gut-repair protocol using prebiotics, probiotics, and fiber diversity Targeted detox and mitochondrial support The GLP-1 therapy was reframed as the gateway to momentum, while the functional repair plan became the runway for long-term metabolic stability. This is the FMU approach in action medication used as a bridge, while deeper system repair creates sustainable transformation
Nucleotide-binding oligomerization domain containing 2 (NOD2) is the first confirmed susceptibility gene for CD, and its mutation is significantly associated with the risk of CD onset [175, 176]